CXXI.F Stock Overview
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
C21 Investments Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.20 |
| 52 Week High | CA$0.47 |
| 52 Week Low | CA$0.15 |
| Beta | 2.29 |
| 11 Month Change | -21.67% |
| 3 Month Change | -20.70% |
| 1 Year Change | -21.70% |
| 33 Year Change | -69.47% |
| 5 Year Change | -60.42% |
| Change since IPO | -21.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| CXXI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -5.3% | -1.4% | 0.3% |
| 1Y | -21.7% | 10.8% | 31.1% |
Return vs Industry: CXXI.F underperformed the US Pharmaceuticals industry which returned 9.8% over the past year.
Return vs Market: CXXI.F underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| CXXI.F volatility | |
|---|---|
| CXXI.F Average Weekly Movement | 17.6% |
| Pharmaceuticals Industry Average Movement | 9.6% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CXXI.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CXXI.F's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 114 | Sonny Newman | www.cxxi.ca |
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services.
C21 Investments Inc. Fundamentals Summary
| CXXI.F fundamental statistics | |
|---|---|
| Market cap | US$25.78m |
| Earnings (TTM) | -US$308.63k |
| Revenue (TTM) | US$26.79m |
0.9x
P/S Ratio-73.8x
P/E RatioIs CXXI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CXXI.F income statement (TTM) | |
|---|---|
| Revenue | US$26.79m |
| Cost of Revenue | US$17.58m |
| Gross Profit | US$9.21m |
| Other Expenses | US$9.52m |
| Earnings | -US$308.63k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0026 |
| Gross Margin | 34.38% |
| Net Profit Margin | -1.15% |
| Debt/Equity Ratio | 3.7% |
How did CXXI.F perform over the long term?
See historical performance and comparison